BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3926086)

  • 21. [Current status of the problem of viral hepatitis B prophylaxis].
    Golosova TV; Vlasikhina EM
    Probl Gematol Pereliv Krovi; 1980 Sep; 25(9):49-55. PubMed ID: 6999496
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis B: an update in relation to dentistry.
    Scully C
    Br Dent J; 1985 Nov; 159(10):321-8. PubMed ID: 2934082
    [No Abstract]   [Full Text] [Related]  

  • 23. [Risk of hepatitis B virus transmission by highly viremic chronic carriers in schools].
    Repp R; Seuchter C; Breitbach B; Lampert F; Gerlich WH
    Zentralbl Hyg Umweltmed; 1993 Feb; 194(1-2):126-33. PubMed ID: 8333890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.
    Chen JD; Yang HI; Iloeje UH; You SL; Lu SN; Wang LY; Su J; Sun CA; Liaw YF; Chen CJ;
    Gastroenterology; 2010 May; 138(5):1747-54. PubMed ID: 20114048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variants of hepatitis B virus associated with fulminant liver disease.
    Shafritz DA
    N Engl J Med; 1991 Jun; 324(24):1737-9. PubMed ID: 2034253
    [No Abstract]   [Full Text] [Related]  

  • 26. Serum hepatitis B virus DNA: relationship with the e-antigen and anti-e status in chronic carriers.
    Yap SF; Wong NW; Goh KL
    Malays J Pathol; 1994 Jun; 16(1):57-62. PubMed ID: 16329577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serologic markers of hepatitis B virus infection.
    Hoofnagle JH; Schafer DF
    Semin Liver Dis; 1986 Feb; 6(1):1-10. PubMed ID: 3086979
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of HBs antigen, DNA polymerase activity, and hepatitis B virus DNA in tears: relevance to hepatitis B transmission by tears.
    Gastaud P; Baudouin C; Ouzan D
    Br J Ophthalmol; 1989 May; 73(5):333-6. PubMed ID: 2730853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point mutations in the S and pre-S2 genes observed in two hepatitis B virus carriers positive for antibody to hepatitis B surface antigen.
    Shinji T; Koide N; Hanafusa T; Hada H; Oka T; Takayama N; Shiraha H; Nakamura M; Ujike K; Yumoto Y; Tsuji T
    Hepatogastroenterology; 1998; 45(20):500-2. PubMed ID: 9638436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of high viral hepatitis B virus DNA loads on vertical transmission of hepatitis B virus in late-pregnant women].
    Yang S; Liu M; Wang L
    Zhonghua Fu Chan Ke Za Zhi; 2008 May; 43(5):329-31. PubMed ID: 18953863
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of a homogenous hepatitis B virus population of A1896-containing strains leading to mild resolving acute hepatitis and seroconversion to hepatitis B e antigen antibodies in an adult.
    Mphahlele MJ; Shattock AG; Boner W; Quinn J; McCormick PA; Carman WF
    Hepatology; 1997 Sep; 26(3):743-6. PubMed ID: 9303507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Viral load in hepatitis B e antigen-negative carriers with normal aminotransferase level.
    Liaw YF
    Hepatology; 2007 Sep; 46(3):947; author reply 947-9. PubMed ID: 17705263
    [No Abstract]   [Full Text] [Related]  

  • 33. Infectivity markers in HBsAg chronic carriers and intrafamilial spread of hepatitis B virus infection.
    Pastore G; Dentico P; Angarano G; Lapedota E; Schiraldi O
    Hepatogastroenterology; 1981 Feb; 28(1):20-2. PubMed ID: 7216135
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Natural course and prognosis in asymptomatic carriers of hepatitis B virus].
    Suzuki K; Abe K; Kumagai I
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():227-32. PubMed ID: 15453320
    [No Abstract]   [Full Text] [Related]  

  • 35. [Study on hepatitis B virus in saliva of dental patients].
    Zhu YP; Guo JQ
    Shanghai Kou Qiang Yi Xue; 2017 Oct; 26(5):549-552. PubMed ID: 29308520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of envelope and precore/core variants of hepatitis B virus (HBV) during chronic HBV infection.
    Takayanagi M; Kakumu S; Ishikawa T; Higashi Y; Yoshioka K; Wakita T
    Virology; 1993 Sep; 196(1):138-45. PubMed ID: 8356791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transmission of hepatitis B to patients from four infected surgeons without hepatitis B e antigen.
    Incident Investigation Teams and Others
    N Engl J Med; 1997 Jan; 336(3):178-84. PubMed ID: 8992352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Severe outcome of hepatitis B virus (HBV) infection and lack of HBV e antigen-defective virus emergence in patients homozygous for HLA class I alleles.
    Pollicino T; Pernice F; Campo S; Mesiti O; Misefari V; Pernice M; Raimondo G
    J Gen Virol; 1996 Aug; 77 ( Pt 8)():1833-6. PubMed ID: 8760434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 40. Fifth of e antigen negative carriers of hepatitis B virus should not perform exposure prone procedures.
    Boxall EH; Ballard A
    BMJ; 1997 Jan; 314(7074):144. PubMed ID: 9006484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.